Busting the billion-dollar myth: how to slash the cost of drug development.

Subjects

Subjects :

Africa
Amodiaquine administration & dosage
Amodiaquine therapeutic use
Anti-Bacterial Agents administration & dosage
Anti-Bacterial Agents economics
Anti-Bacterial Agents therapeutic use
Artemisinins administration & dosage
Artemisinins therapeutic use
Benzamides economics
Benzamides therapeutic use
Boron Compounds economics
Boron Compounds therapeutic use
Child
Clinical Trials as Topic economics
Clinical Trials as Topic methods
Cooperative Behavior
Developed Countries economics
Developing Countries economics
Drug Approval
Drug Combinations
Drug Costs
Drug Discovery organization & administration
Drug Industry organization & administration
Drug Repositioning economics
Drug Resistance, Microbial drug effects
Female
Humans
Malaria drug therapy
Neglected Diseases drug therapy
Negotiating
Nitroimidazoles economics
Nitroimidazoles pharmacology
Nitroimidazoles therapeutic use
Sample Size
Trypanosomiasis, African drug therapy
World Health Organization
Drug Discovery economics
Drug Discovery methods
Drug Industry economics
Drug Industry methods
Organizations, Nonprofit economics
Organizations, Nonprofit organization & administration

Details

Language :

English

ISSN :

1476-4687

Volume :

536

Issue :

7617

Database :

MEDLINE

Journal :

Nature

Publication Type :

Periodical

Accession number :

27558048

Full Text :

https://doi.org/10.1038/536388a